Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

Benzodiazepines | DeGuzman

Course outline

Course progress

Not started
2024 Board Exam Preparation: Pre-Assessment
Open/Close details
- Optional
Not started
Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits
Open/Close details
- Optional
Not started
Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits
Open/Close details
- Optional
Not started
Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits
Open/Close details
- Optional
Not started
Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits
Open/Close details
- Optional
Not started
Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability
Open/Close details
- Optional
Not started
Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM
Open/Close details
- Optional
Not started
Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach
Open/Close details
- Optional
Not started
Restructuring Addiction Care Access in Carceral Population and System
Open/Close details
- Optional
Not started
Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,
Open/Close details
- Optional
Not started
SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH
Open/Close details
- Optional
Not started
Youth and Substance Use | Veronika Mesheriakova, MD
Open/Close details
- Optional
Not started
Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use
Open/Close details
- Optional
Not started
Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS
Open/Close details
- Optional
Not started
Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi
Open/Close details
- Optional
Not started
Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova
Open/Close details
- Optional
Not started
Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD
Open/Close details
- Required
Not started
Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD
Open/Close details
- Required
Not started
Knowledge Check: 2023 Board Exam Preparation Assessment
Open/Close details
- Required
Not started
Evaluations
Open/Close details
- Required
Not started
Credit
Open/Close details
- Optional
Not started
Certificate
Open/Close details
- Optional

Expand / Minimize

CSAM Education Center

2024 Addiction Medicine Board Exam Preparation Course

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

2024 Board Exam Preparation: Pre-Assessment

Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits

Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits

Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits

Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM

Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach

Restructuring Addiction Care Access in Carceral Population and System

Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,

SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH

Youth and Substance Use | Veronika Mesheriakova, MD

Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use

Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation

You are here

2024 Addiction Medicine Board Exam Preparation Course

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

2024 Board Exam Preparation: Pre-Assessment

Navigating Pain Management: The Role of Buprenorphine and Methadone Amidst the Opioid Crisis | 3 CME Credits

Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | 3 CME Credits

Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | 3 CME Credits

Motivational Interviewing for Busy Clinicians and Educators | 3.75 CME Credits

Keynote: Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability

Harm Reduction by Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM

Opioids: Long-acting Buprenorphine and Overdose Prevention for Unhoused in Fentanyl Era: A Street Medicine Approach

Restructuring Addiction Care Access in Carceral Population and System

Women and Addiction Team Lily: Rebecca Schwartz, MSW | Dana Lazarovitz, PHN Teresa Rondone, Navigator | Caitlin Felden-Heimer,

SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD MPH

Youth and Substance Use | Veronika Mesheriakova, MD

Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use

Smoking Cessation Intervention in Homeless and Marginally Housed Persons Maya Vijayaraghavan, MD, MAS

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation